Making Sense of the Evolving Standards of Care for Advanced HER2+ Breast Cancer

by Michael Fenimore | Apr 9, 2021 | Uncategorized

The overall goal of this CE initiative is to establish meaningful, small group interactions between clinicians involved in the care of patients with breast cancer that will, through a variety of collaborative educational experiences, help them optimally manage...

Osteoarthritis and Pain: Intensive Training in Pain Management

by Michael Fenimore | Mar 16, 2021 | Uncategorized

Osteoarthritis and Pain: Intensive Training in Pain Management is a comprehensive evidence-based presentation about the burden of osteoarthritis (OA) and OA pain, the challenges of current pharmacologic and nonpharmacologic strategies, and evidence about the role of...

Networks in Neurology: A Virtual Collaboration of Specialists and Practicing Neurologists on the Effective Integration of New Agents and Strategies for Multiple Sclerosis

by Michael Fenimore | Mar 15, 2021 | Uncategorized

MS is the leading cause of non-traumatic disability in adults over the age of 50 and has become a focus of evolving research. In just the past two decades, a greater understanding of the pathogenesis of MS has led to a litany of new FDA approved therapies. In fact,...

Accelerating New Standards of Oncology Care Amidst the Global Pandemic: Operational, Clinical, and Interpersonal Considerations

by Michael Fenimore | Mar 10, 2021 | Uncategorized

There is an urgent and ongoing need to provide cancer care professionals with guidance, training, and support during the COVID-19 pandemic as they respond to unprecedented challenges in maintaining high-quality patient care. Members of the care team are challenged by...

Networks in Neurology: A Virtual Collaboration of Headache Specialists and Practicing Neurologists on the Effective Integration of New Agents and Strategies for Migraine.

by Michael Fenimore | Jan 11, 2021 | Uncategorized

One out of six US adults suffer from migraines and yet, until recently, management has been reliant on treatments designed for other conditions that had some consequential success. Fortunately, this long-standing paradigm has not only ended but has accelerated in the...